| Life Sciences Tools & Services Industry | Healthcare Sector | Mr. Lin Chi-Wen CEO | TWSE Exchange | TW0001527000 ISIN |
| TW Country | 674 Employees | 4 Aug 2025 Last Dividend | 13 Sep 2006 Last Split | - IPO Date |
Lotus Pharmaceutical Co., Ltd., founded in 1966 and based in Taipei City, Taiwan, operates at the forefront of the pharmaceutical industry, focusing on the research, development, manufacture, and international sales of generic pharmaceutical products. With a market presence in Taiwan, South Korea, the United States, and other countries globally, Lotus Pharmaceutical is dedicated to addressing the needs of patients across a wide range of therapeutic areas. The company's business activities extend beyond pharmaceutical manufacturing to include retail of clinical machinery, biotech consulting services, and healthcare consultancy, thereby offering a comprehensive suite of solutions in the healthcare sector. Lotus Pharmaceutical has established a strategic partnership with NRX Pharmaceuticals, underlining its commitment to innovation and excellence in healthcare solutions.
The core of Lotus Pharmaceutical's product line includes generic drugs concentrating on several critical therapeutic areas such as oncology, cardiology, nephrology, women's health, anti-obesity, and central nervous system diseases. Leveraging extensive research and development capabilities, the company offers high-quality, accessible medication options to patients worldwide.
Beyond prescription medications, Lotus Pharmaceutical provides a variety of over-the-counter (OTC) healthcare products, catering to the daily health and wellness needs of consumers. These products offer convenient and immediate relief from common health issues, enhancing the well-being of individuals and families.
In response to the technical needs of healthcare providers, Lotus Pharmaceutical engages in the retail of clinical machines. This service not only supports medical professionals in delivering effective treatments but also ensures patients have access to the latest healthcare technologies.
Lotus Pharmaceutical extends its expertise through biotech technological consulting services, assisting other organizations in navigating the complex landscape of biotechnology. This includes strategy development, technological innovation, and operational guidance, fostering growth and advancement in the biotech sector.
The company offers a range of consultancy services aimed at improving health management and technology practices. This encompasses health technology, trading information services, management consultancy, pharmaceutical regulatory affairs, and project management. Lotus Pharmaceutical's consultancy services are tailored to meet the diverse needs of the healthcare industry, ensuring clients can deliver superior care and services.
As a contract research organization (CRO), Lotus Pharmaceutical fulfills the research and development needs of the pharmaceutical and biotech industries. This service includes data collection, regulatory affairs management, and comprehensive project management for clinical trials, facilitating the development of innovative medical treatments and therapies.